ConductScience.org, home

Paper4469040

Some clinical pharmacological studies with indoramin, with observations on its therapeutic usefulness.

de White C and 2 others. Postgrad Med J, 1974. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Some clinical pharmacological studies with indoramin, with observations on its therapeutic usefulness. Papers, record 4469040. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4469040

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Some clinical pharmacological studies with indoramin, with observations on its therapeutic usefulness.
PubMed
Journal
Postgrad Med J
PubMed
Year
1974
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
1.17
iCite
Revised in PubMed
2019-05-01
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1de White CC
2Royds RBR B
3Turner PP

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HypertensionMajor topic
IndolesMajor topic
IndoraminMajor topic
Adult
Antidepressive Agents, Tricyclic
Antihypertensive Agents
Blood Pressure
Depression
Desipramine
Drug Therapy, Combination
Female
Humans
London
Male
Middle Aged

Source PubMed

Download CSV of topics

References14

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
24402080Pharmacologic studies of indoramin in man.Clin Pharmacol Ther1972https://conductscience.org/library/papers/4402080PubMed
34401308Quantitative analysis on isolated organs of the autonomic blocking properties of indoramin hydrochloride (Wy 21901).Br J Pharmacol1972https://conductscience.org/library/papers/4401308PubMed
44571186Interaction between clonidine and desipramine in man.Br Med J1973https://conductscience.org/library/papers/4571186PubMed
54148431The alpha-adrenoceptor blocking effect of indoramin on human isolated smooth muscle.J Pharm Pharmacol1973https://conductscience.org/library/papers/4148431PubMed
65761914Treatment of hypertension with propranolol.Br Med J1969https://conductscience.org/library/papers/5761914PubMed
75940523Studies on the control of hypertension. 8. Mortality, morbidity, and remissions during twelve years of intensive therapy.Circulation1966https://conductscience.org/library/papers/5940523PubMed
85331494Drugs which lower blood pressure.Trans Med Soc Lond1966https://conductscience.org/library/papers/5331494PubMed
94404395Antagonism of noradrenaline and histamine by desipramine in the isolated artery of the rabbit ear.Br J Pharmacol1972https://conductscience.org/library/papers/4404395PubMed
106071724On resetting of "barostats" in hypertensive patients.JAMA1967https://conductscience.org/library/papers/6071724PubMed
114148430The evaluation of the alpha-adrenoceptor blocking action of indoramin, phentolamine and thymoxamine on the rat and guinea-pig isolated mesenteric vasculature and aortic spiral preparations.J Pharm Pharmacol1973https://conductscience.org/library/papers/4148430PubMed
124359995Clinical evaluation of indoramin, a new antihypertensive agent.Eur J Clin Pharmacol1973https://conductscience.org/library/papers/4359995PubMed
135127116Hypertension and depression: interrelated problems in therapy.J R Coll Physicians Lond1971https://conductscience.org/library/papers/5127116PubMed
144591149Treatment of hypertension with a new beta-blocking agent, pindolol (Visken).Eur J Clin Pharmacol1973https://conductscience.org/library/papers/4591149PubMed
155431666Guanethidine and related agents. 3. Antagonism by drugs which inhibit the norepinephrine pump in man.J Clin Invest1970https://conductscience.org/library/papers/5431666PubMed

Download CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
7437237Evaluation of indoramin added to oxprenolol and bendrofluazide as a third agent in severe hypertension.Br J Clin Pharmacol1980https://conductscience.org/library/papers/7437237PubMed
6405965Alpha blockers and converting enzyme inhibitors.Br Med J (Clin Res Ed)1983https://conductscience.org/library/papers/6405965PubMed
3525084Indoramin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and related vascular, cardiovascular and airway diseases.Drugs1986https://conductscience.org/library/papers/3525084PubMed
60350Drug treatment of hypertension.J Clin Pathol Suppl (R Coll Pathol)1975https://conductscience.org/library/papers/60350PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4469040

GET https://conductscience.org/api/papers/v1/4469040/authors